Human Stem Cells Institute PJSC Logo

Human Stem Cells Institute PJSC

ISKJ | MOEX

Overview

Corporate Details

ISIN(s):
RU000A0JNAB6
LEI:
Country:
Russian Federation
Address:
3 Gubkina Street PO Box 373, 119333  Moscow
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Artgen Biotech PJSC (formerly Human Stem Cells Institute PJSC) is a biotechnology company focused on developing and commercializing innovative platform technologies for the healthcare industry. Operating as a strategic investor, it manages a portfolio of biotech companies at various stages of development, fostering an ecosystem for research and commercialization. The company's core activities center on drug discovery, R&D, and marketing of proprietary products and services in regenerative medicine, gene therapy, and cell-based technologies. Key offerings include biomedical drugs (vaccines, gene therapies), medical devices based on gene-activated materials, and medical services such as biobanking (cord blood stem cells) and genetic research.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Human Stem Cells Institute PJSC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Human Stem Cells Institute PJSC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Human Stem Cells Institute PJSC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL